StockGlow

Nuformix plc (NFX.L)

Develops repurposed drugs to treat fibrosis and cancer

0.16+0.00%Healthcare
Compare NFX.L with
StockGlow Score
10
Bearish
BearishBullish
1 year ago+105.1%

The outlook

Nuformix trades at 0.16p, sitting well below both its 50- and 200-day moving averages and near the lower end of its 52-week range. Analyst coverage appears thin on this stock. The overall sentiment leans decidedly bearish based on current technical positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range18% of the way from its 52-week low to high
Market cap
$4.2M
52-wk high
0.56
52-wk low
0.07
50-day avg
0.18
200-day avg
0.23
Trailing P/E
—

Similar stocks

HEMO.LHemogenyx Pharmaceuticals Plc$635.00-9.22%THAT.LThalia Therapeutics Plc$0.65-3.70%GDR.Lgenedrive plc$0.99-0.76%PYC.LPhysiomics Plc$0.47-3.09%VAL.LValiRx plc$0.16+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy